Clinical Trial: Pilot Study of Longitudinal Plasma PD-L1 Testing with Immunotherapy in Lung Cancer

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849518) titled 'Pilot Study of Longitudinal Plasma PD-L1 Testing with Immunotherapy in Lung Cancer' on Feb. 24.

Brief Summary: This is a prospective pilot study to assess dynamic changes of plasma cell-free RNA (cfRNA) PD-L1 expression in patients with lung cancer undergoing immune checkpoint inhibitor (ICI) based therapy. Results will be correlated with radiographic assessment of immunotherapy treatment response and plasma NGS ctDNA.

Study Start Date: Feb. 11

Study Type: INTERVENTIONAL

Condition: Lung Cancer (NSCLC)

Intervention: DIAGNOSTIC_TEST: Circulogene liquid biopsy testing

A Circulogene liquid biopsy testing for plasma NGS ctDNA and ...